Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage
Related Posts
India Is on a Hiring Binge That Trump’s Tariffs Can’t Stop
An abundance of motivated young professionals is luring American businesses to base their global operations in Indian cities.
China’s Surging Exports Loom Over Trump’s Talks With Xi
China’s exports grew by a quarter in the month of August, weeks before its leader, Xi Jinping, is set to…
Paramount Asks States to Shoulder Costs of Delaying Warner Bros. Deal
Paramount’s $111 billion deal to acquire Warner Bros. Discovery has been postponed until the conclusion of a trial, a delay…